IRESSA 250
Drug Category |
|
Medicinal form |
Tablets |
Active ingredient |
|
Concentration |
250mg |
Manufacturer |
|
Price |
10600 EGP |
Uses
is a first line treatment for patients with EGFR mutation for 1 locally advanced or metastatic,
Uses: effective in esophageal cancer patients whose tumours harboured additional copies of the EGFR gene. there is potential for its use in the treatment of other cancers where EGFR overexpression is involved. Erlotinib is another EGFR tyrosine kinase inhibitor that has a similar mechanism of action to gefitinib.
Note: The information provided about this drug does not substitute for consulting a doctor.
Direct Access to Pharmacy Through Innovative Portal
Empower your health journey with Direct Access to Pharmacy Through Innovative Portal - Your gateway to seamless and efficient healthcare solutions at your fingertips
See list pharmacies